Communication trends in Latin America: How pharma can utilise new and emerging digital platforms
Smartphones and digital technology have revolutionised the way we communicate with one another. Latin America, like other parts of the world, has been swift to embrace new and emerging digital applications, in particular WhatsApp, which has become an ubiquitous tool for people in both their personal lives and in business. As digital communication channels increase in popularity, it is important for the pharmaceutical industry to keep in step. Understanding how to leverage platforms like WhatsApp as both a means of generating customer insight and as a stakeholder engagement tool, will help pharma companies to have impact in this exciting and ever-changing region.
The digital patient
Comparing usage and attitudes in mature and emerging markets
We may talk about always putting the patient at the heart of healthcare, but in some less established world markets, is this feasible? The rise of chronic diseases in some regions, combined with an ageing and growing population, is putting unbearable pressure on health-care systems already at capacity.
Like, Like, Like: How pharmaceutical companies can harness the power of social media insights
Given the colossal amount of personal and professional information that we share online, social media channels such as Facebook and Twitter are fast becoming treasure troves of big data. As the popularity and diversity of platforms increases, so too does their utility for healthcare market research. Combined with the continuous stream of user-generated content, advances in research technology now allow marketers to tap into social media data to understand more about the healthcare landscape.
A common reality: How augmented reality is transforming the future of pharmaceutical marketing
In the second installment of a three-part series exploring virtual and augmented reality, Harrison Gaiger explores the ways in which AR is transforming the future of pharmaceutical marketing.
In a previous article I explored the growing role that Virtual Reality (VR) is playing in the healthcare industry, including its use as a marketing tool for pharmaceutical companies, and questioned what the future of VR may look like in a world where technological advancements are being made every day. It seemed clear to me that while VR is still in the early stages of medical application, it’s already making a huge impact on the healthcare industry and that, regardless of its infancy, VR technology is most likely here to stay. Because of this I concluded by saying that tech-savvy pharmaceutical marketers should consider adding it to their future strategies as an invaluable means for engaging with customers. In the second instalment of this three-part series, I look at the ways in which Augmented Reality (AR) is transforming the future of pharmaceutical marketing.
Game changer? The role of virtual reality in healthcare
In the first installment of three-part series exploring virtual and augmented reality, Harrison Gaiger outlines the medical applications of VR and how pharma can leverage this innovative technology in the future.
The next decade promises to be an exciting time for science and innovation. Technological advancements are being made on a daily basis and many of these have the potential to directly impact our everyday lives. In fact, technology is changing at such a rate that it can often seem difficult to keep up. One technological advancement with the potential to change how we interact with technology and each other is Virtual Reality (VR) – immersive computer-generated environments that place users in seemingly life-like situations with which they can interact. VR, once the stuff of science-fiction, is now becoming a viable mainstream product.